OHK Medical Devices Company
"Orthopedic, Vascular Surgery, and Emergency Medicine Products."
OHK Medical Devices manufactures and sells products for orthopedic surgery, vascular surgery, and emergency medicine. Its core patent-protected technology is a line of single-use devices designed to quickly and effectively displace blood from the limbs and block its re-entry.
OHK's HemaClear line of sterile surgical products are widely used to create a bloodless surgical field. The company also developed the EED product line for use in emergency medicine. The EED system is used to auto-transfuse a patient's own blood from their limbs into central circulation during severe shock or cardiopulmonary resuscitation. HemaClear is FDA listed and CE marked.
In November 2018, the company launched HemaShock, an emergency auto-transfusion tourniquet that is used to squeeze blood out of the legs (also arms if needed) and block reentry of arterial blood flow into those limbs. This can be done quickly by a single caregiver even during transport. The HemaShock is indicated for use in patients who have very low systolic blood pressure (i.e. less than 80 mm Hg) due to hemodynamic shock or circulatory (cardiac) arrest.
In February 2020, the company started developing ViriMASK, a patent-pending face mask to provide protection from viruses and more.
Combating Coronavirus Pandemic:
OHK Medical Devices's solution helps address the Coronavirus Pandemic.
OHK Medical Devices manufactures and sells products for orthopedic surgery, vascular surgery, and emergency medicine. Its core patent-protected technology is a line of single-use devices designed to quickly and effectively displace blood from the limbs and block its re-entry.
OHK's HemaClear line of sterile surgical products are widely used to create a bloodless surgical field. The company also developed the EED product line for use in emergency medicine. The EED system is used to auto-transfuse a patient's own blood from their limbs into central circulation during severe shock or cardiopulmonary resuscitation. HemaClear is FDA listed and CE marked.
In November 2018, the company launched HemaShock, an emergency auto-transfusion tourniquet that is used to squeeze blood out of the legs (also arms if needed) and block reentry of arterial blood flow into those limbs. This can be done quickly by a single caregiver even during transport. The HemaShock is indicated for use in patients who have very low systolic blood pressure (i.e. less than 80 mm Hg) due to hemodynamic shock or circulatory (cardiac) arrest.
In February 2020, the company started developing ViriMASK, a patent-pending face mask to provide protection from viruses and more.
Combating Coronavirus Pandemic:
OHK Medical Devices's solution helps address the Coronavirus Pandemic.
Technology:
COVID Treatments
Industry:
Preventive Tech
Headquarters:
Israel
Founded Date:
2002
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership